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Tuesday, March 9, 2021
During this COVID-19 pandemic and other future events, the CDM has been
and will continue to be a source of reliable information, education and models
for mitigation, preparedness, response, and recovery. We hope this
informational document has helped provide you filtered and actionable
information. As the pace of new information and changes occur, we will
evaluate the current once per week to determine if this information should be
provided on a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total
Recovered

Total Tested

Worldwide

117,188,008

2,601,043

66,393,113

Not Available

United States

29,045,448

525,816

Not Available

363,789,451

New Jersey

814,916

23,590

Not Available

10,999,550

New York

1,700,091

48,401

Not Available

39,695,100

Connecticut

287,396

7,725

Not Available

6,520,366

Information as of 3/9/21 at 0600 EST. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
●
●
●
●

Delivered All Hazards Disaster Response course to members of different public safety
agencies from New York and Connecticut.
Presented invited lecture regarding COVID-19 response and best practices to graduate
students enrolled in Master in Homeland Security degree in Guatemala.
Coordinating and overseeing COVID-19 screenings at NYMC campus
Continue to partner with local agencies such as Westchester Department of Emergency
Services to ensure ongoing collaboration with all public safety agencies.

●
●
●
●
●
●

Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.

To view the Center for Disaster Medicine's newest webinar, please click here - The
COVID-19 Vaccine: What to Tell Your Patients

Federal
•

•

The Centers for Disease Control and Prevention (CDC) issued its first set
of recommendations on activities that people who are fully vaccinated against COVID-19 can
safely resume. The new guidance—which is based on the latest science — includes
recommendations for how and when a fully vaccinated individual can visit with other people
who are fully vaccinated and with other people who are not vaccinated. This guidance
represents a first step toward returning to everyday activities in our communities. CDC will
update these recommendations as more people are vaccinated, rates of COVID-19 in the
community change, and additional scientific evidence becomes available.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html
The Department of Veterans Affairs (VA) received 71,400 doses of the Janssen COVID-19
vaccine, March 3, authorized by the U.S. Food and Drug Administration under an
Emergency Use Authorization. In clinical trials, the Janssen vaccine showed an efficacy of
66% against moderate to severe/critical COVID-19 disease occurring at least 28 days after
vaccination — and demonstrated greater than 85% efficacy in preventing severe/critical
COVID-19 disease occurring at least 28 days after vaccination.
https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5632

The White House
The official website of the White House will deliver bold action and immediate relief for American
families as the country grapples with converging crises. This will include actions to control the
COVID-19 pandemic, provide economic relief, tackle climate change, and advance racial equity
and civil rights, as well as immediate actions to reform our immigration system and restore
America’s standing in the world. This website will provide all information in one central location.
https://www.whitehouse.gov

Health and Human Services (HHS)
President Biden announced on March 2, 2021, that his Administration has helped forge a historic
manufacturing collaboration between two of the largest U.S. health care and pharmaceutical
companies, Merck and Johnson & Johnson (J&J), to expand production of J&J’s COVID-19
vaccine. The collaboration will increase manufacture of vaccine drug substance, as well as its
fill-finish capacity – two of the biggest bottlenecks facing J&J in the production of its vaccine.
https://www.hhs.gov/about/news/2021/03/02/biden-administration-announces-historicmanufacturing-collaboration-between-merck-johnson-johnson-expand-production-covid-19vaccines.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
The National Institutes of Health has launched the last of three Phase 3 clinical trials to evaluate
the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults
diagnosed with COVID-19. The first patient in the trial was enrolled on February 15.
https://www.nih.gov/news-events/news-releases/statement-nih-starting-enrollment-third-trialblood-clotting-treatments-covid-19
The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational
therapeutics for COVID-19 in hospitalized patients, has closed enrollment in two sub-studies:
one examining the investigational monoclonal antibody therapy VIR-7831, and another
evaluating the investigational combination monoclonal antibody therapy containing BRII-196 and
BRII-198.
https://www.nih.gov/news-events/news-releases/nih-sponsored-activ-3-clinical-trial-closesenrollment-into-two-sub-studies
The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness
of COVID-19 convalescent plasma in treating emergency department patients who developed
mild to moderate symptoms of COVID-19, the disease caused by the coronavirus SARS-CoV-2.

https://www.nih.gov/news-events/news-releases/nih-halts-trial-covid-19-convalescent-plasmaemergency-department-patients-mild-symptoms
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
As of March 5, 2021, 337 tests and sample collection devices are authorized by the FDA
under emergency use authorizations (EUAs). These include 251 molecular tests and
sample collection devices, 71 antibody tests and 15 antigen tests. There are 38 molecular
authorizations that can be used with home-collected samples. There is one molecular
prescription at-home test, two antigen prescription at-home test, and one over-the-counter
(OTC) at-home antigen test.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-updatemarch-5-2021

On March 5, 2021, the U.S. FDA issued an emergency use authorization (EUA) for the TDetect COVID Test developed by Adaptive Biotechnologies. The T-Detect COVID Test is
a next generation sequencing based (NGS) test to aid in identifying individuals with an
adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with
SARS-CoV-2.
https://www.fda.gov/news-events/press-ann ouncements/coronavirus-covid-19-updatefda-authorizes-adaptive-biotechnologies-t-detect-covid-test
On March 5, 2021, the U.S. FDA issued an emergency use authorization (EUA) for the
Cue COVID-19 Test for Home and Over The Counter (OTC) Use. The product is a
molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material
from SARS-CoV-2 virus present in the nostrils. The test is the first molecular test
authorized for at-home use without a prescription.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdaissues-authorization-first-molecular-non-prescription-home-test
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Centers for Disease Control and Prevention (CDC)
Comprehensive prevention measures are critical strategies to reduce the burden of
SARS-CoV-2 in the United States. These prevention measures include wearing a mask,
maintaining at least six feet of physical distance from others, avoiding crowds, avoiding
poorly ventilated spaces, hand hygiene, cleaning and disinfection, following CDC travel
guidance, and following workplace or school guidance related to personal protective
equipment use or SARS-CoV-2 testing 1.
https://www.cdc.gov/coronavirus/2019-ncov/more/fully-vaccinated-people.html
The emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are significant to
public health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides update on COVID-19 cases caused by variants in the United States.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
For daily updates of cases in United States
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

Center for Medicare and Medicaid Services (CMS)
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of March 9, 2021, the FDA has granted Emergency
Use Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson.
Now with three vaccines with EUA, the goal is to vaccinate a larger number of persons in
the coming months throughout the United States. As additional vaccines are granted
EUA, information for those vaccines will also be included.
On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use
authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in
individuals 18 years of age and older.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/janssen-covid-19-vaccine
On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use
authorization (EUA) for the second vaccine for the prevention of coronavirus disease
2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be
distributed in the U.S for use in individuals 18 years of age and older.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/moderna-covid-19-vaccine
On December 11, 2020, the U.S. Food and Drug Administration issued the first
emergency use authorization (EUA) for a vaccine for the prevention of coronavirus
disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization
allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019covid-19/pfizer-biontech-covid-19-vaccine
The CDC issuesd new guidance—which is based on the latest science — for how and
when a fully vaccinated individual can visit with other people who are fully vaccinated and
with other people who are not vaccinated. This guidance represents a first step toward
returning to everyday activities in our communities. CDC will update these
recommendations as more people are vaccinated, rates of COVID-19 in the community
change, and additional scientific evidence becomes available.
https://www.cdc.gov/media/releases/2021/p0308-vaccinated-guidelines.html
CDC provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts,
and data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal

Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
On March 8, 2021, Governor Mario M. Cuomo announced that more than 40,000 doses of
the COVID-19 vaccine have been administered at community-based pop-up sites in
houses of worship throughout New York State. More than 22,500 first doses and more
than 18,000 second doses have been administered. 48 pop-up sites have been
established in houses of worship. Partnering with houses of worship builds on New York's
efforts to bring the vaccine to underserved communities across the state.
https://www.governor.ny.gov/news/governor-cuomo-announces-more-40000-covid-19vaccine-doses-administered-new-york-houses-worship
The new NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on
the distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
NYS DOH releases instructions for New York State-operated vaccination sites
https://covid19vaccine.health.ny.gov/
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
•

Higher Education

o

o

•

K-12
o

Congress is poised to send another $40 billion in aid to the nation’s
colleges and universities after the Senate approved a $1.9 trillion
coronavirus relief bill Saturday. The House is expected to pass the
measure -- which contains the largest infusion of help to higher education
approved by Congress during the pandemic -- as soon as Tuesday,
sending it to President Biden for his signature. Biden called the Senate’s
passage of the bill “historic” and a “giant step forward” in providing help to
Americans during the pandemic. The money will be distributed to public
and private institutions. Colleges and universities are required to spend at
least half of the money on emergency grants to students. Whether
undocumented and international students can get the help, however, still
hasn't been decided by the Education Department.
https://www.insidehighered.com/news/2021/03/08/senate-approves-40billion-colleges
The coronavirus pandemic is reinvigorating hunger-free campus
legislation in states including Maryland, Massachusetts and New York,
where lawmakers recently proposed bills that would provide colleges with
financial and administrative assistance for helping food-insecure
students. State lawmakers are becoming more aware of the needs of
the diversifying student population, said Sunny Deye, director of the
postsecondary education program at the National Conference of State
Legislatures. Today's students were already more likely to be working
adults, first generation and low income, and to require additional support
with basic needs such as food, housing and childcare, Deye said. Then
came the pandemic, which caused students and their families to lose
employment and income. The result is a broad swath of students who are
at risk of dropping out, she said.
https://www.insidehighered.com/news/2021/03/05/legislators-revisitefforts-pass-hunger-free-campus-laws
In several ways, the public health crisis has hampered students' exposure
to reading and literacy. Students learning remotely may have fewer
opportunities to hold books in their hands and practice turning pages left
to right. Those learning in-person are finding classroom bookshelves
empty or limited due to safety protocols. But in other ways, the pandemic
is allowing educators to be more purposeful and resourceful when it
comes to promoting literacy, reading experts say.Immersing students in
rich text, engaging them in conversations about a book’s characters, plot
and scenery, and creating positive associations with books can occur in
any learning format, Bassford said. So can scaffolding strategies to help
struggling readers, she added. https://www.k12dive.com/news/howteachers-are-inspiring-students-to-read-during-the-pandemic/596092/

Clinical Trials
To view the latest information on 4,636 clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates
New York
•

•

•

Governor Andrew M. Cuomo announced that beginning April 2, event, arts and
entertainment venues can reopen at 33 percent capacity, up to 100 people indoors and
up to 200 people outdoors. If all attendees present proof of negative test prior to
entry, capacity can increase up to 150 people indoors and up to 500 people outdoors.
Social distancing and face coverings will be required by all attendees, as well as strict
adherence to all applicable Department of Health guidance. Governor Cuomo also
announced domestic travelers to New York State who have been vaccinated no longer
have to quarantine or test out within 90 days of their full vaccination. Governor Cuomo
also announced that beginning March 22, residential gatherings of up to 25 people can
be held outdoors. Indoor residential gatherings remain capped at 10 people to reduce
the continued risk of spread. Also, non-residential social gatherings of up to 100 people
can occur indoors and up to 200 people can occur outdoors.
https://www.governor.ny.gov/news/governor-cuomo-announces-event-arts-andentertainment-venues-can-reopen-33-percent-capacity
Governor Cuomo announced $29 million is available to support essential workers and
first responders through the Empire Pandemic Response Reimbursement Fund program
coordinated by the Office of Children and Family Services. The program is designed to
reimburse out-of-pocket childcare, transportation, lodging and other qualifying expenses
that enabled workers to perform their duties. The funding comes from private donations
from individuals, charitable trusts and businesses made during the COVID crisis.
https://www.governor.ny.gov/news/governor-cuomo-announces-29-million-availablesupport-essential-workers-and-first-responders
Governor Cuomo announced that restaurants outside of New York City, which have
been operating at 50 percent capacity, can now move to 75 percent capacity starting
March 19. The data has shown that restaurants can operate safely and in accordance
with strict health protocols at 75 percent capacity. New York City restaurant capacity will
remain at 35 percent capacity. https://www.governor.ny.gov/news/governor-cuomoannounces-restaurants-outside-new-york-city-can-move-75-percent-indoor-capacity

New York State Department of Health (DOH)
On March 8, 2021, Governor Cuomo announced the mass vaccination site at the Jacob K. Javits
Convention Center in New York City performed best in the nation from Saturday through
Monday. The site administered 13,431 doses over a 24-hour period on Saturday and Sunday,
and 13,713 doses over a 24-hour period on Sunday and Monday. 123,124 doses have been
administered across New York's vast distribution network in the last 24 hours. The total week 12
federal vaccine allocation has been delivered to providers for administration. As of 11 a.m.today,

New York providers have administered 89 percent of first doses so far delivered. The week 13
allocation from the federal government begins mid-week.
https://www.governor.ny.gov/news/governor-cuomo-announces-best-single-day-performancenation-javits-center-mass-vaccination-site
For a list of positive cases by county in New York State
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
•

•

Governor Phil Murphy signed Executive Order No. 228, allowing indoor wedding
receptions to operate at 35 percent capacity of the room in which they are held, up to
150 individuals, and outdoor wedding receptions to permit up to 150 individuals. Both
capacity limits are exclusive of venue staff. Receptions will be required to follow indoor
and outdoor dining guidance, which requires that people eat and drink while seated and
wear face coverings at all other times. Additionally, Governor Murphy today indicated
that overnight camps will be permitted to resume operations for the summer
season. The Governor and the Department of Health will issue additional guidance
regarding the application process and the applicable health and safety protocols in the
coming weeks. https://nj.gov/infobank/eo/056murphy/pdf/EO-228.pdf
Governor Murphy signed Executive Order No. 229, extending a moratorium preventing
New Jersey residents from having their utilities disconnected through at least June 30,
2021. The moratorium was previously set to expire on March 15, 2021, pursuant to
Executive Order No. 190 (2020). The moratorium applies to all residential gas, electric
and water utilities, both public and private. Further, the utilities will not be permitted to
charge late fees nor fees to reconnect services that have been disconnected.
https://nj.gov/infobank/eo/056murphy/pdf/EO-229.pdf

Connecticut
•

Governor Ned Lamont today announced that in the coming days he plans to revise some
requirements that were implemented in Connecticut in the onset of the COVID-19
pandemic, particularly when it comes to those relating to capacity levels and travel
restrictions. The governor stressed that while some of these restrictions are being eased,
all of the protocols that relate to face coverings, social distancing, and cleaning measures
are being maintained, and people and businesses are urged to continue adhering to those
health and safety procedures. https://portal.ct.gov/Office-of-the-Governor/News/PressReleases/2021/03-2021/Governor-Lamont-Announces-Plans-To-Ease-Some-COVID19-Restrictions-in-Connecticut

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
NYC DOHMH provides FAQs for healthcare providers- On March 5, 2021, NYC DOHMH provides
this FAQs which covers a wide range of topics regarding COVID-19 for healthcare providers.
https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-provider-faqs.pdf
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page

Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of March 7, 2021
https://wcgis.maps.arcgis.com/apps/opsdashboard/index.html#/280339d96db14efd9cc304dba0f3a71
d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus

Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of March 8, 2021https://www.putnamcountyny.com/breakdown-of-positive-cases-by-towns-in-putnam-county-3-82021/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of March 8, 2021
https://dcny.maps.arcgis.com/apps/opsdashboard/index.html#/8905f4428f3148d0bffd50a2f3e4db11
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of March 8, 2021
https://ocnygis.maps.arcgis.com/apps/opsdashboard/index.html#/21de1fb5ce0c480f95dc0cf2b8b83b
71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
March 8, 2021
https://www.arcgis.com/apps/opsdashboard/index.html#/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/

Healthcare
GNYHA provides updated New York Stat guidance information regarding Johnson & Johnson
COVID-19 Vaccine Emergency Use Authorization
https://www.gnyha.org/news/johnson-updated-new-york-state-guidance/
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Center for Disaster Medicine Media
New York Medical College Leadership News:
Why You Shouldn't Feel Guilty for Getting Your COVID-19 Vaccine
HuffPost

3/4/2021
https://www.huffpost.com/entry/feel-guilty-covid-shot_l_603fb3c3c5b682971504a496
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Line Up For 3rd Coronavirus Vaccine Just Like The Others: Expert
Patch
3/2/2021
https://patch.com/new-york/nyack/line-3rd-coronavirus-vaccine-just-others-expert
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Children May Start to Be Vaccinated for COVID-19 in the Fall: Why That’s Important
Healthline
3/2/2021
https://www.healthline.com/health-news/children-may-start-to-be-vaccinated-for-covid-19-inthe-fall-why-thats-important
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
Faculty News:
COVID Long-Haulers: An End in Sight?
ASHA Leader Online
3/5/2021
https://leader.pubs.asha.org/do/10.1044/leader.FTR1.26032021.42/full/
Luis F. Riquelme, Ph.D., CCC-SLP, BCS-S, associate professor of speech-language
pathology and director of the Advanced Certificate Program in Pediatric Dysphagia

Every effort is made to provide accurate and complete information in this newsletter. However, New
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of
this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the
advice of your physician or other qualified health provider with any questions you may have regarding a
medical condition.

New York Medical College
Center for Disaster Medicine
7 Dana Road Suite 511
Valhalla, New York 10595
914-594-1750

https://www.nymc.edu/center-for-disaster-medicine/

